Search for: "Ortho McNeil Pharmaceutical Inc"
Results 141 - 160
of 182
Sort by Relevance
|
Sort by Date
10 Jun 2009, 9:02 pm
Seeking approval to market a generic version of levofloxacin, Defendants-Appellants Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc. filed an Abbreviated New Drug Application (ANDA) with the FDA. [read post]
26 May 2009, 2:13 pm
From a May 13, 2009 Law.com article, "Levaquin Tendon Injury Mass Tort Treatment Sought for Suits Over Ortho-McNeil Antibiotic Levaquin": Users of Levaquin, an antibiotic linked to muscle ailments, are asking the New Jersey Supreme Court to accord mass-tort treatment to their suits against the manufacturer, Johnson & Johnson subsidiary Ortho-McNeil Pharmaceutical Inc. [read post]
13 May 2009, 1:31 am
Mass-Tort Treatment Sought for Suits Over Ortho-McNeil Antibiotic Levaquin
New Jersey Law Journal
Users of Levaquin, an antibiotic linked to muscle ailments, are asking the New Jersey Supreme Court to accord mass-tort treatment to their suits against the manufacturer, Johnson & Johnson subsidiary Ortho-McNeil Pharmaceutical. [read post]
21 Apr 2009, 8:45 am
Ortho-McNeil, Inc., No. [read post]
15 Apr 2009, 8:56 pm
By Suresh Pillai -- Resolution Announced in Johnson & Johnson Razadyne ® ER Patent Litigation Johnson & Johnson units Janssen LP, Janssen Pharmaceutica NV, and Ortho-McNeil Neurologics have stipulated to a dismissal with prejudice of all claims of patent infringement against KV Pharmaceutical Co., Barr Pharmaceuticals Inc., and Sandoz Inc. with respect to a generic version of Razadyne ® ER. [read post]
20 Mar 2009, 2:05 am
Sterling Drug, Inc., 416 F.2d 417, 426 (2d Cir. 1969).District of Columbia: McNeil Pharmaceutical v. [read post]
4 Feb 2009, 4:09 pm
Product liability cases against large conglomerates like Ortho-McNeil-Janssen Pharmaceuticals, Inc., can often be more than most attorneys can handle. [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic Effexor… [read post]
29 Aug 2008, 1:25 pm
: (IP finance), Facebook removes international access to Scrabulous, except from India: (Ars Technica), (Techdirt), Reverse engineering can resolve conflict between standardisation and competition: (Techdirt), Benefits of piracy aren’t always in the expected places: (Techdirt) Events 1-3 September: Federation of Indian Chambers of Commerce and Industry, Department of Industrial Property and Promotion, and WIPO conference on ‘Development and IP: Building synergies… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
1 Aug 2008, 12:33 pm
§ 1407 and Transfers Actions to District of Minnesota Fifteen (15) individual and class action lawsuits were filed in seven (7) different federal district courts against Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc., and Johnson & Johnson Pharmaceutical Research & Development, among others, alleging “that the antibiotic Levaquin causes tendon rupture, and the warnings provided by defendants… [read post]
28 Jul 2008, 7:01 pm
" In Ortho-McNeil Pharmaceutical, Inc. v. [read post]
25 Jul 2008, 2:11 am
In Ortho-McNeil Pharmaceutical, Inc. v. [read post]
11 Jul 2008, 4:30 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
2 May 2008, 7:00 am
: (Spicy IP), Ultracet (Tramadol) – Barr and Caraco win summary judgment that Ortho-McNeil’s formulation patent on Ultracet is invalid: (Orange Book Blog), Xopenex (Levosalbutamol) – US: Sepracor, Breath settle Xopenex patent fight: (IP Law360), (GenericsWeb), Africa African copyright & access to knowledge (ACA2K) project launched: (Michael Geist), (Afro-IP), Seven reasons why Prof Odek should be the next WIPO DG: (Afro-IP), … [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram)… [read post]
13 Apr 2008, 8:19 pm
Ortho-McNeil Pharmaceutical, Inc. v. [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro (Escitalopram)… [read post]
9 Apr 2008, 8:49 pm
By Donald Zuhn -- Last week, the Federal Circuit issued an opinion in Ortho-McNeil Pharmaceutical, Inc. v. [read post]
